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Abstract. The widespread unregulated use of antibiotics without medical consultation contributes to the burden of
antibiotic resistance in Southeast Asian countries. This study investigated antibiotic use before hospital consultation. In a
prospective observational study from February 2, 2015, to July 2, 2015, we enrolled febrile patients attending the
emergency room inSanLazaroHospital,Manila, thePhilippines. Aurine samplewascollectedandabioassaywasused to
detect antibiotic activity in urine using Bacillus stearothermophilus (ATCC7953), Escherichia coli (ATCC25922), and
Streptococcus pyogenes (ATCC19615). Patients or caregivers reported their medication history, clinical information, and
socioeconomic status. During the study period, 410 patients were enrolled. The median (interquartile range) age was 14
(7–23) years and 158 (39%) reported prior antibiotic use, predominantly a beta-lactamantibiotic. A total of 164 (40%, 95%
conﬁdence interval [CI]: 35–45) patients were urine bioassay positive with any of three organisms. TheBacillus assaywas
themost sensitive, detecting 162 (99%, 95%CI: 96–100) cases. Amongbioassay positive patients, dengue (N= 91, 55%,
95% CI: 48–63) was the most frequent diagnosis, followed by other viral infections, including measles, rubella, and
mumps (N=17, 10%, 95%CI: 6–16). Patientswith a positive bioassaywere signiﬁcantlymore likely to be from the lowest-
income group (adjusted odds ratio [AOR]: 1.7; 95% CI: 1.1–2.6) and required hospital admission (AOR: 2.1; 95% CI:
1.3–3.5). Unnecessary antibiotic use for febrile illnesses before hospital consultation is common in a low-income, highly
populated urban community in Manila. Education targeting this group should be implemented to reduce unnecessary
antibiotic use.
INTRODUCTION
Antibiotic resistance is a major public health problem
worldwide.1 The rapid emergence and spread of antibiotic
resistance have been reported inmany countries.2,3 Infections
with antibiotic resistant organisms are associated with higher
mortality, prolonged illness, and increased health-care costs be-
cause of additional diagnostic tests and antibiotic therapies.4,5
Unregulated use of antibiotics is common in many resource-
limited countries and one of the factors contributing to the high
prevalence of antibiotic resistance.1,6,7
In the Philippines, despite the existing legislative framework
to control antibiotic use, the unregulated sale of antibiotics
without medical prescription is widespread.8,9 Even those
with a low-income can afford to purchase low-priced generic
antibiotics without a medical consultation. People may prefer
antibiotics over the counter because of the possible additional
costs, efforts, and time incurredwhenvisiting health facilities.9
Thewidespread use of antibiotics beforemedical consultation
can result in a signiﬁcantly lower yield of the causative path-
ogen inmicrobiology tests.10,11 This can lead tomisdiagnosis,
delay of proper treatment, and poor surveillance of resistance.
Understanding the prevalence of community antibiotic use
is useful information for providing amore appropriate medical
management in health care facilities and for developing
stewardship strategies to control resistance in thecommunity.
Several studies have shown that self-reporting by patients or
caregivers about the history of recent antibiotics can be un-
reliable.12 Laboratory bioassay methods have been used to
detect antibiotic activity in body ﬂuid specimens as ameasure
of antibiotic use.13,14 Relatively high rates of antibiotic use
detected by the bioassay have been reported in Southeast
Asia.15–17 Limited information is available on the prevalence of
antibiotic use before medical consultation in low-income
communities in the Philippines. We conducted a prospective
hospital-based observational study investigating prior antibi-
otic use in patients attending theSanLazaroHospital (SLH) for
a medical consultation.
MATERIALS AND METHODS
Setting. We performed a prospective observational study,
in single health facility in Manila City, Metro Manila (ofﬁcially
called as National Capital Region), the Philippines. The SLH is
a 500-bed tertiary hospital specializing in infectious diseases.
This national government hospital is the National Infectious
Disease Referral Center and is also a major care provider for
people from the low-incomearea inManila city. This hospital is
located in one of the most economically depressed and
densely populated districts in the country. Although SLH is a
tertiary care referral hospital, most outpatients in the emer-
gency room (ER) are walk in and live around the hospital.
Patients. This study was conducted each weekday be-
tween 9 AM and 4 PM from February 2, 2015 to July 2, 2015. All
patients aged more than 12 months who presented with fever
or a history of fever with onset within the last 2 weeks were
enrolled during the recruitment period. Subjects aged less
than 12 months , previously diagnosed with human immuno-
deﬁciency virus (HIV), with on-going treatment of tuberculosis
(TB), or a history of hospital admission within the previous
month were excluded. Subjects unable to provide urine were
also excluded from this study.
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Samples and data. After providing written informed con-
sent, sociodemographic and clinical information of the patient
or patient’s caregiver were collected using a standard ques-
tionnaire. Socioeconomic information included area of resi-
dence and patient’s or caregiver’s monthly income. The
clinical diagnosis made by the attending physician, the
physical examination ﬁndings, antibiotic use during this ill-
ness, and the name of antibiotics were documented by the
researcher. Urine samples were collected before the initiation
of antibiotics in the hospital. The samples were promptly
transported to the laboratory for aliquoting and storage in
a−80C freezer until later testing in the bioassay. Twenty urine
samples of healthy volunteers with no history of consumption
of any antibiotics within the previous 2 weeks were also
obtained as negative controls.
Laboratory methods. A disc diffusion method, as pre-
viously described by Liu et al.,18 was used to measure anti-
biotic activity in the urine samples. Three indicator organisms
prepared to a 0.5 Macfarland concentration were inoculated
on agar in Petri dishes. Mueller-Hinton agar was used for the
Bacillus stearothermophilus (ATCC 7953) and Escherichia coli
(ATCC 25922), Mueller-Hinton agar with 5% sheep blood was
used for Streptococcus pyogenes (ATCC 19615). Three mi-
croliters of urine was applied to 6-mmdiameter discs of sterile
ﬁlter paper which had been placed on the lawns of each or-
ganism. The plates of S. pyogenes and E. coliwere incubated
at 35Candat 56C forB. stearothermophilus for 18–24hours.
After incubation, the zone diameter of inhibited bacterial
growth surrounding each ﬁlter paper disc was measured.
Data analysis.Statistical analysis of patient characteristics
and urine bioassay result was conducted using the χ2 test or
Fisher’s exact test for categorical variables and the t test for
numerical variables. To investigate the effect of various vari-
ables on prior antibiotic use and hospitalization as required by
the attending physician, an unadjusted and adjusted logistic
regressionmodel was used. Adjustedmodels included values
for age group (1–4, 5–18, 19–64, 64 over years old), sex, du-
ration of symptom, living area, and symptoms which were
signiﬁcant relation with the urine bioassay result. Data were
managed using Microsoft Access, and statistical analyses
were performed using the Stata software (Stata Statistical
Software Release 13; Stata Corp., College Station, Texas).
Values of P < 0.05 were considered signiﬁcant.
Ethical consideration. All participants, or for children their
parent or guardian, were asked to give informed written con-
sent at the time of enrollment. Ethical approval was obtained
from the Research and Ethical Review Board of SLH, the
Philippines, and the Institutional Review Board of the Institute
of Tropical Medicine, Nagasaki University, Japan.
RESULTS
The total number of patient consultations in the ER was
8,375 during the study period. One thousand three hundred
and twenty three patients visited from Monday to Friday be-
tween 9 AM and 4 PM. Among them, 545 subjects were ex-
cluded because the reason for consultation was after an
animal bite (N = 53), they were being treated for TB or HIV (N =
21), aged less than1 year (N=85), not a febrile illness (N=361),
refused (N = 9) and were unable to provide urine (N = 16).
Among possibly eligible subjects, 410 (53%) patients agreed
to be enrolled in this study. For organizational reasons, the
remaining 368 patients were not seen by the study team. The
examination of the ER ledger for these patients revealed that
some may have been eligible for the study but it was not
possible to determine the exact number.
The urine bioassaywas positive for antibiotic activity for any
of the three organisms in 164 (40%, 95% conﬁdence interval
[CI]: 35–45) samples. One hundred and sixty two (99%, 95%
CI: 96–100) of the positive samples were detected by the
plates with B. stearothermophilus. The plates with E. coli and
S. pyogenesdetected85 (52%,95%CI: 44–60) and120 (73%,
95% CI: 66–80) of any positive assay, respectively. Although
the assay of S. pyogeneswas not able to detect further cases
additional with B. stearothermophilus, the assay of E. coli
showed further two cases (1.2%, 95%CI: 0.1–4). According to
the self-reports, in these two additional cases co-trimoxazole
and ciproﬂoxacin had been taken. None of the 20 healthy
volunteers had antibiotic activity detected in their urine.
Table 1 shows the relationship between patient antibiotic
use based on self-reports and the bioassay. The urine bio-
assay showed 122 (80.8%, 95% CI: 73.6–86.7) positive urine
assays among subjects who reported to take antibiotics dur-
ing the illness. There were 42 (16.2%, 95% CI: 11.9–21.3)
positive urine assays among subjects who reported not taking
antibiotics and 29 (19.2%, 95% CI: 13.2–26.4) subjects who
reported antibiotic usebut showedanegative urine assay. The
positive predicted value and negative predict value of self-
reports were 80.8% and 83.8%, respectively.
According to patients’ self-reporting, the main source of
antibiotics was community pharmacies followed by private
clinics and public health centers (Tables 2). None of the
patients reported obtainingmedication from friends, relatives,
or charities. Most antibiotics were beta-lactams including
amoxicillin, cloxacillin, amoxicillin/clavulanate, and oral
cephalosporins. The usage of ﬂuoroquinolones was small
(8%). Most of the patients took antibiotics for less than
7 days (91%).
Dengue fever was most the common clinical diagnosis
among enrolled patients (N = 200, 48.8%, 95%CI: 43.8–53.7)
and patients with positive urine bioassay (N = 91, 55.5%, 95%
CI: 47.5–63.2) (Table 3). This was followed by other viral in-
fection, such as measles, rubella, mumps (N = 17, 10.4%,
95% CI: 6.2–16.1), upper respiratory infection (N = 14,
8.5%, 95%CI: 4.7–13.9), and acute gastroenteritis (N = 14,
8.5%, 95% CI: 4.7–13.9).
The association between the characteristics of enrolled
patients and the urine bioassay results is shown in Table 4.
There was no signiﬁcant difference in the age group, sex, and
the living area between the subjects with the positive and
negative result. Patients presentingwith a rashwere less likely
to have a positive urine bioassay but patients presenting with
abdominal pain or arthralgiaweremore likely to haveapositive
result. A longer duration of symptoms was observed in
TABLE 1
Relationship between patients self-reported antibiotic use and urine
bioassay results
Self-reported antibiotic use
Positive urine bioassay Negative urine bioassay
N = 144 N = 246
n (%) n (%)
Yes N = 151 122 (80.8) 29 (19.2)
No N = 259 42 (16.2) 217 (83.8)
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patients with a positive urine bioassay. Signiﬁcant differences
in the proportion with a positive bioassay were observed be-
tween the low income group (income < 5,000 Philippine pesos
[PHP]/month) and the higher income group (income ³ 5,000
PHP/month) (adjusted odds ratio [AOR]: 1.78; 95% CI:
1.17–2.72). Furthermore, a higher risk of subsequent admis-
sion from theERwasobserved amongpatientswhohad taken
antibiotics before their consultation as indicated by a positive
urine bioassay (unadjusted odds ratio [OR]: 2.50; 95% CI:
1.56–4.00, AOR: 1.96; 95% CI: 1.17–3.29; Table 5).
DISCUSSION
This study, using an objective urinary bioassay, has dem-
onstrated that a high proportion of people used antibiotics
before hospital consultation in a low-incomeurban population
in the Philippines. According to the diagnosis by the attending
physician in the hospital, denguewasby far themost common
diagnosis and most antibiotics were unnecessary.
Our study found that a substantial proportion of patients/
caregivers reported taking the antibiotics which were pur-
chased in a local pharmacy. We were unable to identify
whether the purchases were based on the doctor’s pre-
scription. We assume that certain proportion of our enrolled
subjects purchased antibiotics without medical consultation
or prescription. In the Philippines, although a medical pre-
scription is ofﬁcially required to obtain antibiotics, recent re-
ports indicate that inappropriate selling of antibiotics without
prescription occurs in community drug stores.9
We found a signiﬁcant association between the monthly
income of patients and a positive urine bioassay result. The
average income per month in the Philippines is about 9,449
Philippine Peso which is equivalent to 215 US dollars.19 The
economic status of our studied population was lower than
this average. In Manila, inexpensive generic antibiotics are
widely available.8,9 We recently visited three local community
pharmacies where antibiotics were available without a pre-
scription and generic antibiotics were available at low cost:
amoxicillin/capsule (500mg) 5.5–6.6 PHP (0.11–0.13US dollar);
TABLE 2
Characteristics of the self-reported antibiotic use and the proportion with antibiotics detected and not detected by urine bioassay
Self-reported n (%) Urine antibiotic activity detected n (%) Urine antibiotic activity not detected n (%) P value*
Total 151 (36.8) 122 (80.8) 29 (19.2) –
Source of antibiotic
Pharmacy 91 (60.3) 70 (57.4) 21 (72.4) 0.454
Private clinic 25 (16.6) 21 (17.2) 4 (13.8)
Public health center 22 (14.6) 20 (16.4) 2 (6.9)
Hospital 13 (8.6) 11 (9.0) 2 (6.9)
Antibiotic taken
Amoxicillin 35 (23.2) 28 (23.0) 7 (24.1) 0.081
Cloxacillin 25 (16.6) 22 (18.0) 3 (10.3)
Amoxicillin/
clavulanate
24 (15.9) 20 (16.4) 4 (13.8)
Oral cephalosporins 12 (8.0) 12 (9.8) 0 (0)
Co-trimoxazole 18 (11.9) 14 (11.5) 4 (13.8)
Fluoroquinolones 8 (5.3) 5 (4.1) 3 (10.3)
Macrolide 3 (2.0) 2 (1.6) 1 (3.5)
Chloramphenicol 2 (1.3) 0 (0.0) 2 (6.9)
Metronidazole 2 (1.3) 1 (0.8) 1 (3.5)
Others 4 (2.7) 4 (3.3) 0 (0)
Unknown 18 (11.9) 14 (11.5) 4 (13.8)
Duration of antibiotics
1 day 49 (32.5) 38 (31.2) 11 (37.9) 0.016
2–3 days 64 (42.4) 55 (45.1) 9 (31.0)
4–6 days 23 (15.2) 21 (17.2) 2 (6.9)
More than 1 week 15 (9.9) 8 (6.6) 7 (24.1)
Living area
Manila city 64 (42.4) 51 (41.8) 13 (44.8) 0.943
Metro Manila but
outside Manila city
72 (47.7) 59 (48.4) 13 (44.8)
Outside Metro
Manila
15 (9.9) 12 (9.8) 3 (10.3)
Monthly income
(PHP)†
³ 5,000 56 (37.1) 43 (32.3) 13 (44.8) < 0.05
< 5,000 95 (62.9) 79 (64.8) 16 (55.2)
* Pearson’s χ2 test, comparing mean between urine bioassay positive and negative.
†PHP = Philippines peso (100 PHP = 2 US dollar).
TABLE 3
Clinical diagnosis at emergency room in the San Lazaro Hospital and
the results of urine antibiotic bioassay
Total
Urine antibiotic activity
detected
N = 410 N = 164
n (%) n (%)
Dengue 200 (48.8) 91 (55.5)
Upper respiratory infection 31 (7.6) 14 (8.5)
Lower respiratory infection 27 (6.6) 7 (4.2)
Acute gastroenteritis 27 (6.6) 14 (8.5)
Urinary tract infection 15 (3.7) 3 (1.8)
Other viral infection (including
measles, rubella, mumps)
79 (19.3) 17 (10.4)
Enteric fever 7 (1.7) 4 (2.4)
Soft tissue infection 2 (0.5) 2 (1.2)
Others 19 (4.6) 11 (6.7)
Unknown 3 (0.7) 1 (0.6)
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amoxicillin/clavulanate/tablet (500/125mg) 25–50 PHP (0.5–1
US dollar); trimethoprim-sulfamethoxazole/tablet (800/160
mg) 5–10 PHP (0.1–0.2 US dollar); and levoﬂoxacin/tablet
(500mg) 25–45PHP (0.5–0.9USdollar). Althoughmost public
health clinics provide freemedical consultation and drugs,
we speculate that patients/caregivers obtain antibiotics in
their local pharmacies because they might consider the cost
higher inmedical facilities than thecost in thepharmacydue to
their poor knowledge. Long waiting time in health facilities is
considered to be another factor leading people to go to the
pharmacy without medical consultation in Manila.
A few other studies have described a relationship between
economic status and antibiotic use.20,21 The opposite result
from our ﬁndingwas observed in Nigeria in that children with a
higher socioeconomic status were more likely to have con-
sumed antibiotics before the consultation to tertiary hospi-
tals.22 The authors of this study suggested that children living
in a higher-economic status area tended to go to private
clinics which were more likely to prescribe antibiotics. In our
setting, most patients attending this hospital had a low-
income and, in contrast with the study in Nigeria, there were
very few with a high-income. There may also be a relationship
between low economic status and low educational attainment
although our study did not determine the educational level
of subjects. A study in Albania found that people with low
education level were more likely to use antibiotics without
prescription.23 These results suggested that to reduce un-
necessary antibiotic use, it is important to provide knowledge
and education about acute febrile illness targeting the low-
income group.
Studies about antibiotic use before the medical consulta-
tionusinga laboratorybioassay todetect antibiotic activity in a
body ﬂuid have been conducted in various settings (Table 6).
The inclusion criteria in these studies and their target pop-
ulation have varied (e.g., children or adults, outpatients or in-
patients, and febrile or all patients).11,12,15–18,22,24–33 In view of
the different inclusion criteria it is difﬁcult to compare the an-
tibiotic use indifferent settings. Furthermore, the various types
of body ﬂuid specimen and indicator organisms were used in
each study. The results of antibiotic use reported by previous
studies have varied between 20% and 80% (Table 6). Recent
studies in Cambodia and Laos using a urine bioassay method
similar to ours showed that 32% and 50% of outpatients had
urinary antibiotic activity, respectively.15,16 Our prevalence of
urine antibiotic activity (40%, 95% CI: 34–47) was similar to
these results from Southeast Asian countries. We observed a
higher level of agreement between self-reported antibiotic use
and antibiotic activity detected in the urine than those of other
previous reports (Table 6). Among patients/caregivers who re-
ported taking antibiotics before their medical consultation, our
urine assay detected antibiotic activities in 80.8% (95% CI:
67–96). Most patients enrolled in our study were able to name
the antibiotic they had used. A previous study study conducted
in the Philippines in 1980s showed a signiﬁcant gap between
the self-reports and evidence of antibiotic activity.28 The
results of our current study suggest that the self-reporting of
antibiotic usewas relatively reliable in this areaand that people
have awareness of their antibiotic use at a community level.
Signiﬁcant relationships between antibiotic use and some
symptoms were found. While patients who had abdominal
TABLE 4
Associations between patient characteristics and the urine bioassay result
Urine bioassay result
Negative n (%) Positive n (%) Unadjusted OR (95% CI) AOR* (95% CI)
Overall 246 (60.0) 164 (40.0) – –
Sex (male) 139 (56.5) 104 (63.1) 1.33 (0.89–2.00) 1.35 (0.88–2.08)
Age group (years old)
1–4 93 (37.8) 59 (36.0) Ref Ref
5–18 42 (17.1) 19 (11.6) 0.71 (0.38–1.34) 0.90 (0.45–1.81)
19–64 110 (44.7) 82 (50.0) 1.18 (0.76–1.81) 1.30 (0.81–2.08)
64 over 1 (0.4) 4 (2.4) 6.31 (0.69–57.8) 8.12 (0.82–80.81)
Symptom
Cough 117 (47.6) 88 (53.7) 1.28 (0.86–1.90) –
Headache 161 (65.5) 110 (67.1) 1.08 (0.71–1.63) –
Sputum 82 (33.3) 67 (40.9) 1.38 (0.92–2.08) –
Runny nose 74 (30.1) 59 (36.0) 1.31 (0.86–1.99) –
Sore throat 77 (31.3) 52 (31.7) 1.02 (0.67–1.56) –
Dyspnea 70 (28.5) 52 (31.7) 1.17 (0.76–1.79) –
Abdominal pain† 110 (44.7) 91 (55.5) 1.54 (1.04–2.29) 1.40 (0.91–2.15)
Diarrhea 27 (11.0) 24 (14.6) 1.39 (0.77–2.51) –
Rash† 103 (41.9) 48 (29.3) 0.57 (0.38–0.88) 0.59 (0.38–0.93)
Myalgia 92 (37.4) 62 (37.8) 1.02 (0.68–1.53) –
Arthralgia† 87 (35.4) 75 (45.7) 1.54 (1.03–2.31) 1.59 (1.01–2.51)
Mean duration of symptom (days)‡ 4.3 5.1 1.11 (1.03–1.19) 1.11 (1.03–1.20)
Living area
Manila city 116 (47.2) 72 (43.9) Ref Ref
Metro Manila but outside Manila city 104 (42.3) 78 (47.6) 1.21 (0.80–1.83) 1.13 (0.72–1.77)
Outside Metro Manila 26 (10.6) 14 (8.5) 0.87 (0.47–1.77) 0.59 (0.27–1.31)
Monthly income (PHP)†
³ 5,000 123 (50.0) 57 (34.8) Ref Ref
< 5,000 123 (50.0) 107 (65.2) 1.88 (1.25–2.82) 1.75 (1.15–2.68)
AOR = adjusted odds ratio; CI = conﬁdence interval; OR = odds ratio; PHP = Philippines peso (100 PHP = 2 US dollar); Ref = reference.
* Adjusted for age group, sex, duration of symptom, living area, presence of rash, presence of abdominal pain, presence of arthralgia, and monthly income group.
†P < 0.05 by Pearson’s χ2 test, comparing proportion between urine bioassay positive and negative group.
‡P < 0.05 by t test, comparing mean between urine bioassay positive and negative group.
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pain or arthralgia were more likely to take antibiotics before
medical consultation, patients presenting with a rash were
less likely to take antibiotics. This may be because patients/
caregiver tend to consider that a rash indicates a serious
condition that shouldbe seenat a hospital whereas abdominal
pain or arthralgia may be considered less serious and for
which antibiotics may be taken without medical consultation.
Abdominal pain is a commonsymptom indenguepatients and
oneof the important warning signs.34 Because dengue fever is
a very common infectious disease in Philippines and antibiotic
use is not necessary, these factors suggested that the edu-
cation for people who had abdominal pain is also necessary in
dengue endemic area.
Several different bacteria have been used as indicator or-
ganisms in the urinary bioassay. Almost 99% of positive sam-
ples in this study were detected using B. stearothermophilus.
Similar ﬁndings were obtained in studies in Cambodia and
Laos.15,16 It ispossible theassayprocesscouldbesimpliﬁedby
usingonlyoneorganism.Thiswill dependon the local patternof
antibiotic use; ﬂuoroquinolones, not commonly used in these
three settings but common in others, may not be reliably de-
tected using B. stearothermophilus.15,16
There are several limitations in our study.Wecalculated that
only 53% of potentially eligible patients agreed to participate
in the study. This was based on the examination of the ER
ledger for patients we missed being able to approach. We
could not be sure that the missed patients would have been
eligible, but this did introduce a probable selection bias. The
study period was only during the daytime and in the dry
season. During the rainy season in the Philippines, the
number of consultation increases due to dengue fever, lep-
tospirosis, and acute gastritis. Thus, the study may not be
fully representative of febrile patients seen at the ER in the
SLH. Our study subjects were mainly drawn from a low-
economic status population, did not include middle and high
income participants, and therefore may not be a represen-
tative of community antibiotic use in a fully representative
population in the Philippines. The urine bioassay could un-
derestimate antibiotic use as it may only detect some anti-
biotics, such as beta-lactams and erythromycin, for 12–24
hours after taking a single dose.32 We did not determine the
timing of antibiotic exposure in relation to the time of the urine
sample which might have added more precision to our esti-
mates. Moreover, antibiotics, such as chloramphenicol and
doxycycline, are predominantly metabolized by the liver with
only a small proportion of antibiotic excreted in the urine.13
According to self-reports of antibiotic use in our enrolled
subjects, the use of these antibiotic was uncommon.
Freezing and thawing of the urine sample may have led to a
loss of antibiotic activity. False positive results may occur
due to other agents present in the urine exerting antibacterial
activity.16 Recall bias by the patient/caregiver may lead to an
inaccurate measure of self-reported antibiotic consumption.
We were also unable to conﬁrm the diagnosis of enrolled
TABLE 5
Associations between patient characteristics on admission, the urine bioassay result and the patients that required hospitalization
Required hospitalization to SLH
No Yes Unadjusted
AOR* (95% CI)n (%) n (%) OR (95% CI)
Total 122 (29.8) 287 (70.2) – –
Sex (male) 71 (58.2) 172 (59.9) 1.07 (0.70–1.65) 1.04 (0.64–1.70)
Age group
1–4 38 (31.2) 113 (39.4) Ref Ref
5–18 19 (15.6) 42 (14.6) 0.74 (0.69–1.43) 1.21 (0.54–2.71)
19–64 64 (52.5) 128 (44.6) 0.67 (0.42–1.08) 0.76 (0.43–1.33)
65 over 1 (0.8) 4 (1.4) 1.35 (0.15–12.40) 0.90 (0.80–10.15)
Presence of symptoms during the febrile illness
Cough 61 (50.0) 144 (50.2) 1.01 (0.66–1.54) –
Headache 77 (63.1) 193 (67.3) 1.20 (0.77–1.87) –
Sputum 47 (38.5) 102 (35.5) 0.88 (0.57–1.36) –
Runny nose 44 (36.1) 89 (31.0) 0.80 (0.51–1.24) –
Sore throat 41 (33.6) 88 (30.7) 0.87 (0.56–1.37) –
Dyspnea 30 (24.6) 92 (32.1) 1.45 (0.89–2.34) –
Abdominal pain† 40 (32.8) 160 (55.8) 2.58 (1.65–4.03) 2.11 (1.28–3.47)
Diarrhea† 5 (4.1) 46 (16.0) 4.46 (1.73–11.53) 5.85 (1.94–17.60)
Rash 47 (38.5) 104 (36.2) 0.91 (0.59–1.40) –
Myalgia† 31 (25.4) 122 (42.5) 2.17 (1.36–3.47) 1.52 (0.84–2.76)
Arthralgia† 31 (25.4) 130 (45.3) 2.43 (1.52–3.89) 2.01 (1.14–3.56)
Duration of symptom (mean days)‡ 3.7 5 1.26 (1.12–1.41) 1.23 (1.09–1.38)
Comorbidity§ 28 (23.1) 54 (18.8) 1.26 (1.12–1.41) 0.84 (0.47–1.50)
Living area†
Manila city 73 (59.8) 114 (39.7) Ref Ref
Metro Manila but outside Manila city 40 (32.8) 142 (49.5) 2.27 (1.44–3.59) 2.29 (1.43–3.66)
Outside Metro Manila 9 (7.4) 31 (10.8) 2.21 (0.99–4.90) 1.63 (0.70–3.76)
Monthly income (PHP)
³ 5,000 61 (50.0) 119 (41.5) Ref –
< 5,000 61 (50.0) 168 (58.5) 1.41 (0.92–2.16) –
Prehospital antibiotic use conﬁrmed by urine bioassay†
31 (25.4) 132 (50.0) 2.50 (1.56–4.00) 1.99 (1.17–3.39)
AOR = adjusted odds ratio; CI = conﬁdence interval; OR = odds ratio; PHP = Philippines peso (100 PHP = 2 US dollar); Ref = reference; SLH = San Lazaro hospital.
* Adjusted for age group, sex, duration of symptom, living area, presence of any comorbidity, presence of abdominal pain, presence of diarrhea, presence ofmyalgia, presence of arthralgia, rash.
†P < 0.05 by Pearson’s χ2 test, comparing proportion between patients required to be admitted to SLH and those who was not required.
‡P < 0.05 by t test, comparing mean between patients required to be admitted to SLH and those who were not required.
§ Subjects who have a comorbidity were deﬁned as patients who had taken regular medicine for chronic diseases.
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patients which were relied on clinical diagnosis by the at-
tending physicians in the SLH.
CONCLUSION
This study, conducted in a densely populated, low-income,
anddengue endemic area inManila, provides further evidence
that a signiﬁcant proportion of patients presenting to hospital
with fever have already taken antibiotics. Interestingly the
lowest-income group was more likely to use antibiotics
compared with other groups. Further studies are needed to
clarify the impact of education on the proper management of
acute febrile illness to reduce unnecessary antibiotic use in a
low-income population.
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